Nuclear Trafficking of the HIV-1 Pre-Integration Complex Depends on the ADAM10 Intracellular Domain.

Mark A. Endsley,Anoma D. Somasunderam,Guangyu Li,Numan Oezguen,Varatharasa Thiviyanathan,James L. Murray,Donald H. Rubin,Thomas W. Hodge,William A. O'Brien,Briana Lewis,Monique R. Ferguson
DOI: https://doi.org/10.1016/j.virol.2014.02.006
IF: 3.513
2014-01-01
Virology
Abstract:Previously, we showed that ADAM10 is necessary for HIV-1 replication in primary human macrophages and immortalized cell lines. Silencing ADAM10 expression interrupted the HIV-1 life cycle prior to nuclear translocation of viral cDNA. Furthermore, our data indicated that HIV-1 replication depends on the expression of ADAM15 and γ-secretase, which proteolytically processes ADAM10. Silencing ADAM15 or γ-secretase expression inhibits HIV-1 replication between reverse transcription and nuclear entry. Here, we show that ADAM10 expression also supports replication in CD4(+) T lymphocytes. The intracellular domain (ICD) of ADAM10 associates with the HIV-1 pre-integration complex (PIC) in the cytoplasm and immunoprecipitates and co-localizes with HIV-1 integrase, a key component of PIC. Taken together, our data support a model whereby ADAM15/γ-secretase processing of ADAM10 releases the ICD, which then incorporates into HIV-1 PIC to facilitate nuclear trafficking. Thus, these studies suggest ADAM10 as a novel therapeutic target for inhibiting HIV-1 prior to nuclear entry.
What problem does this paper attempt to address?